SENATE 1544118th CongressRead twice and referred to the Committee on Finance.
Facilitating Innovative Nuclear Diagnostics Act of 2023
- Last Action
- 5/10/2023
Actions
- 2023-05-10Read twice and referred to the Committee on Finance.
- 2023-05-10Introduced in Senate
CRS Summary
As of 2023-05-10 (00)
Facilitating Innovative Nuclear Diagnostics Act of 2023
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.
Cosponsors (7)
- Tammy Baldwin (D-WI)
- Shelley Capito (R-WV)
- Maggie Hassan (D-NH)
- Susan Collins (R-ME)
- Tammy Duckworth (D-IL)
- Cindy Hyde-Smith (R-MS)
- Jeanne Shaheen (D-NH)
Subjects
- Health care costs and insurance
- Medical tests and diagnostic methods
- Medicare
- Radiation
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.